This provider's $9.7M in total Medicare payments ranks in the 98th percentile of Independent Diagnostic Testing Facility (IDTF) providers nationally.
Medicare payments to this provider grew 129% from 2014 to 2023.
68% of their billing comes from a single procedure code (78815 — Nuclear medicine study with CT imaging skull base to mid-thigh).
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $3.5K | $907.30 | 3.87x | $2.6K | $695.7K | 910 | 727 |
| 2015 | $3.5K | $894.48 | 3.91x | $2.6K | $514.9K | 681 | 548 |
| 2016 | $3.7K | $1.2K | 3.01x | $2.5K | $631.0K | 803 | 639 |
| 2017 | $3.1K | $1.1K | 2.88x | $2.1K | $846.8K | 1.0K | 785 |
| 2018 | $2.7K | $785.31 | 3.50x | $2.0K | $815.7K | 1.0K | 830 |
| 2019 | $2.8K | $792.41 | 3.50x | $2.0K | $986.2K | 1.2K | 914 |
| 2020 | $2.9K | $825.16 | 3.49x | $2.1K | $1.0M | 1.2K | 895 |
| 2021 | $3.2K | $1.2K | 2.71x | $2.0K | $1.2M | 1.4K | 1.0K |
| 2022 | $3.4K | $875.43 | 3.90x | $2.5K | $1.4M | 1.6K | 1.2K |
| 2023 | $3.4K | $880.92 | 3.87x | $2.5K | $1.6M | 1.8K | 1.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 5.2K | $6.6M | $1.3K | 4.26x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 5.5K | $2.0M | $370.16 | 2.11x |
| 78816 | Nuclear medicine study with CT imaging whole body | 603 | $765.8K | $1.3K | 4.22x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 221 | $103.2K | $467.13 | 1.28x |
| Q9982 | Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries | 30 | $68.8K | $2.3K | 1.28x |
| 78814 | Nuclear medicine study with CT imaging | 53 | $62.6K | $1.2K | 4.23x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 134 | $42.6K | $318.12 | 1.48x |
| A9597 | Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified | 15 | $36.0K | $2.4K | 1.27x |
| A9586 | Florbetapir f18, diagnostic, per study dose, up to 10 millicuries | 12 | $27.5K | $2.3K | 1.29x |
This provider submits charges 3.73 times higher than what Medicare actually pays.
A markup ratio of 3.73x means for every $100 Medicare pays, this provider initially charges $373. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data